{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:40:10Z","timestamp":1756392010839,"version":"3.44.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000995","name":"Australian National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The malarial parasite <jats:italic>Plasmodium<\/jats:italic> can acquire resistance to most mainstay antimalarial drugs, necessitating the development of new antiplasmodial agents with different modes of action. The innate defense protein, human platelet factor 4 (PF4), has a unique antiplasmodial action that involves selective entry into <jats:italic>Plasmodium<\/jats:italic>-infected red blood cells (RBC) and subsequent destruction of the parasite\u2019s digestive vacuole (DV). This activity is recapitulated in PF4-derived internalization peptides (PDIPs). Here, we characterized the actions of PDIP analogs and PF4 in live <jats:italic>P. falciparum<\/jats:italic>-infected human RBC to understand their kinetics, effects on cell and parasite viability, and molecular requirements for antiplasmodial activity. The entry and accumulation of PDIP, and peptide-induced DV destruction, were distinguishable as ordered and rapidly occurring events that were equivalent to PF4. Both host cell and parasite plasma membranes remained intact and undamaged following destruction of the DV, although modest changes in phosphatidylserine (PS) exposure on the surface of the host cells (indicative of changes to its phospholipid organization) and swelling (but not lysis) of the intracellular parasite were observed. PDIP retained its macrocyclic structure, and its activity depended on elevated levels of PS on the surface of infected versus uninfected cells. Neither the intramolecular disulfide bond of PDIP, nor the parasite\u2019s nutrient and ion transporter functions were required. These actions on the parasite DV were not detected for other antiplasmodial drugs and compounds. In conclusion, this study reveals the unique, rapid, and distinct antiplasmodial actions of PDIP, highlighting its potential for future antimalarial development.<\/jats:p>","DOI":"10.1007\/s00018-025-05757-y","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T12:31:45Z","timestamp":1749472305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into platelet factor 4-derived peptide macrocycles; the mechanistic basis of their rapid and selective antiplasmodial actions"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4814-8367","authenticated-orcid":false,"given":"Dianne W.","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Raven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Woodcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Munro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella R.","family":"Palombi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin L.","family":"Gare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara R.","family":"Malins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-8872","authenticated-orcid":false,"given":"Brendan J.","family":"McMorran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"5757_CR1","unstructured":"World Malaria Report (2023) 1st edn. 2023. World Health Organization,\u00a0Geneva. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023"},{"issue":"1","key":"5757_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12936-022-04115-8","volume":"21","author":"CV Plowe","year":"2022","unstructured":"Plowe CV (2022) Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malar J 21(1):104. https:\/\/doi.org\/10.1186\/s12936-022-04115-8","journal-title":"Malar J"},{"issue":"10","key":"5757_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","volume":"22","author":"JL Siqueira-Neto","year":"2023","unstructured":"Siqueira-Neto JL et al (2023) Antimalarial drug discovery: progress and approaches. Nat Rev Drug Discov 22(10):807\u2013826. https:\/\/doi.org\/10.1038\/s41573-023-00772-9","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"5757_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM et al (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361(5):455\u2013467. https:\/\/doi.org\/10.1056\/NEJMoa0808859","journal-title":"N Engl J Med"},{"key":"5757_CR5","doi-asserted-by":"publisher","first-page":"102193","DOI":"10.1016\/j.mib.2022.102193","volume":"69","author":"KE Ward","year":"2022","unstructured":"Ward KE, Fidock DA, Bridgford JL (2022) Plasmodium falciparum resistance to artemisinin-based combination therapies. Curr Opin Microbiol 69:102193. https:\/\/doi.org\/10.1016\/j.mib.2022.102193","journal-title":"Curr Opin Microbiol"},{"issue":"8","key":"5757_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3201\/eid2208.160004","volume":"22","author":"M Boulle","year":"2016","unstructured":"Boulle M et al (2016) Artemisinin-resistant Plasmodium falciparum K13 mutant alleles, Thailand-Myanmar border. Emerg Infect Dis 22(8):1503\u20131505. https:\/\/doi.org\/10.3201\/eid2208.160004","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"5757_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison S et al (2015) Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis 211(5):670\u2013679. https:\/\/doi.org\/10.1093\/infdis\/jiu491","journal-title":"J Infect Dis"},{"issue":"13","key":"5757_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B et al (2021) Evidence of artemisinin-resistant Malaria in Africa. N Engl J Med 385(13):1163\u20131171. https:\/\/doi.org\/10.1056\/NEJMoa2101746","journal-title":"N Engl J Med"},{"issue":"13","key":"5757_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","volume":"389","author":"S Mihreteab","year":"2023","unstructured":"Mihreteab S et al (2023) Increasing prevalence of artemisinin-resistant HRP2-negative Malaria in Eritrea. N Engl J Med 389(13):1191\u20131202. https:\/\/doi.org\/10.1056\/NEJMoa2210956","journal-title":"N Engl J Med"},{"issue":"10","key":"5757_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A et al (2020) Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med 26(10):1602\u20131608. https:\/\/doi.org\/10.1038\/s41591-020-1005-2","journal-title":"Nat Med"},{"issue":"6870","key":"5757_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389\u2013395. https:\/\/doi.org\/10.1038\/415389a","journal-title":"Nature"},{"issue":"12","key":"5757_CR12","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"RE Hancock","year":"2006","unstructured":"Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551\u20131557. https:\/\/doi.org\/10.1038\/nbt1267","journal-title":"Nat Biotechnol"},{"issue":"9","key":"5757_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","volume":"29","author":"LT Nguyen","year":"2011","unstructured":"Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29(9):464\u2013472. https:\/\/doi.org\/10.1016\/j.tibtech.2011.05.001","journal-title":"Trends Biotechnol"},{"key":"5757_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3389\/fimmu.2020.00983","volume":"11","author":"DSJ Ting","year":"2020","unstructured":"Ting DSJ et al (2020) Strategies in translating the therapeutic potentials of host defense peptides. Front Immunol 11:983. https:\/\/doi.org\/10.3389\/fimmu.2020.00983","journal-title":"Front Immunol"},{"issue":"2","key":"5757_CR15","doi-asserted-by":"publisher","first-page":"e24246","DOI":"10.1002\/pep2.24246","volume":"114","author":"AS Amiss","year":"2022","unstructured":"Amiss AS, Henriques ST, Lawrence N (2022) Antimicrobial peptides provide wider coverage for targeting drug-resistant bacterial pathogens. Pept Sci 114(2):e24246. https:\/\/doi.org\/10.1002\/pep2.24246","journal-title":"Pept Sci"},{"issue":"3","key":"5757_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238\u2013250. https:\/\/doi.org\/10.1038\/nrmicro1098","journal-title":"Nat Rev Microbiol"},{"key":"5757_CR17","doi-asserted-by":"publisher","unstructured":"Le CF, Fang CM, Sekaran SD (2017) Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother 61(4). https:\/\/doi.org\/10.1128\/AAC.02340-16","DOI":"10.1128\/AAC.02340-16"},{"key":"5757_CR18","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.blre.2023.101155","volume":"64","author":"Z Liu","year":"2024","unstructured":"Liu Z et al (2024) Platelet factor 4(PF4) and its multiple roles in diseases. Blood Rev 64:101155. https:\/\/doi.org\/10.1016\/j.blre.2023.101155","journal-title":"Blood Rev"},{"issue":"6","key":"5757_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrmicro3269","volume":"12","author":"MR Yeaman","year":"2014","unstructured":"Yeaman MR (2014) Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol 12(6):426\u2013437. https:\/\/doi.org\/10.1038\/nrmicro3269","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"5757_CR20","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1128\/IAI.70.12.6524-6533.2002","volume":"70","author":"YQ Tang","year":"2002","unstructured":"Tang YQ, Yeaman MR, Selsted ME (2002) Antimicrobial peptides from human platelets. Infect Immun 70(12):6524\u20136533. https:\/\/doi.org\/10.1128\/IAI.70.12.6524-6533.2002","journal-title":"Infect Immun"},{"issue":"11","key":"5757_CR21","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1128\/AAC.48.11.4395-4404.2004","volume":"48","author":"NY Yount","year":"2004","unstructured":"Yount NY et al (2004) Platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide. Antimicrob Agents Chemother 48(11):4395\u20134404. https:\/\/doi.org\/10.1128\/AAC.48.11.4395-4404.2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"5757_CR22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood-2018-05-849307","volume":"132","author":"S Kho","year":"2018","unstructured":"Kho S et al (2018) Platelets kill circulating parasites of all major Plasmodium species in human malaria. Blood 132(12):1332\u20131344. https:\/\/doi.org\/10.1182\/blood-2018-05-849307","journal-title":"Blood"},{"issue":"6","key":"5757_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.chom.2012.10.017","volume":"12","author":"MS Love","year":"2012","unstructured":"Love MS et al (2012) Platelet Factor 4 Activity against P. falciparum and Its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe 12(6):815\u2013823. https:\/\/doi.org\/10.1016\/j.chom.2012.10.017","journal-title":"Cell Host Microbe"},{"issue":"6112","key":"5757_CR24","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1126\/science.1228892","volume":"338","author":"BJ McMorran","year":"2012","unstructured":"McMorran BJ et al (2012) Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 338(6112):1348\u20131351. https:\/\/doi.org\/10.1126\/science.1228892","journal-title":"Science"},{"issue":"3","key":"5757_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bbamem.2006.11.010","volume":"1768","author":"MR Yeaman","year":"2007","unstructured":"Yeaman MR et al (2007) Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins. Biochim Biophys Acta 1768(3):609\u2013619. https:\/\/doi.org\/10.1016\/j.bbamem.2006.11.010","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"5757_CR26","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.chembiol.2018.06.009","volume":"25","author":"N Lawrence","year":"2018","unstructured":"Lawrence N et al (2018) Defense peptides engineered from human platelet factor 4 kill Plasmodium by selective membrane disruption. Cell Chem Biol 25(9):1140-1150.e5. https:\/\/doi.org\/10.1016\/j.chembiol.2018.06.009","journal-title":"Cell Chem Biol"},{"issue":"8","key":"5757_CR27","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1021\/acsinfecdis.4c00276","volume":"10","author":"N Lawrence","year":"2024","unstructured":"Lawrence N et al (2024) Enhancing the Intrinsic antiplasmodial activity and improving the stability and selectivity of a tunable peptide scaffold derived from human platelet factor 4. ACS Infect Dis 10(8):2899\u20132912. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00276","journal-title":"ACS Infect Dis"},{"issue":"5\u20136","key":"5757_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000067908","volume":"12","author":"S Eda","year":"2002","unstructured":"Eda S, Sherman IW (2002) Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cell Physiol Biochem 12(5\u20136):373\u2013384. https:\/\/doi.org\/10.1159\/000067908","journal-title":"Cell Physiol Biochem"},{"issue":"6 Pt A","key":"5757_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.parint.2016.07.007","volume":"65","author":"D Engelbrecht","year":"2016","unstructured":"Engelbrecht D, Coetzer TL (2016) Plasmodium falciparum exhibits markers of regulated cell death at high population density in vitro. Parasitol Int 65(6 Pt A):715\u2013727. https:\/\/doi.org\/10.1016\/j.parint.2016.07.007","journal-title":"Parasitol Int"},{"issue":"2","key":"5757_CR30","doi-asserted-by":"publisher","first-page":"e1009259","DOI":"10.1371\/journal.ppat.1009259","volume":"17","author":"M Fraser","year":"2021","unstructured":"Fraser M et al (2021) Breakdown in membrane asymmetry regulation leads to monocyte recognition of P. falciparum-infected red blood cells. PLoS Pathog 17(2):e1009259. https:\/\/doi.org\/10.1371\/journal.ppat.1009259","journal-title":"PLoS Pathog"},{"issue":"10","key":"5757_CR31","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/ec.00124-10","volume":"9","author":"L Tawk","year":"2010","unstructured":"Tawk L et al (2010) Phosphatidylinositol 3-phosphate, an essential lipid in Plasmodium, localizes to the food vacuole membrane and the apicoplast. Eukaryot Cell 9(10):1519\u20131530. https:\/\/doi.org\/10.1128\/ec.00124-10","journal-title":"Eukaryot Cell"},{"issue":"3","key":"5757_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0166-6851(85)90059-3","volume":"14","author":"H Ginsburg","year":"1985","unstructured":"Ginsburg H et al (1985) Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells. Mol Biochem Parasitol 14(3):313\u2013322. https:\/\/doi.org\/10.1016\/0166-6851(85)90059-3","journal-title":"Mol Biochem Parasitol"},{"key":"5757_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev-micro-091014-104506","volume":"69","author":"K Kirk","year":"2015","unstructured":"Kirk K (2015) Ion regulation in the Malaria parasite. Annu Rev Microbiol 69:341\u2013359. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104506","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"5757_CR34","doi-asserted-by":"publisher","first-page":"13542","DOI":"10.1038\/s41598-019-49841-3","volume":"9","author":"C Brandstaedter","year":"2019","unstructured":"Brandstaedter C et al (2019) The interactome of 2-Cys peroxiredoxins in Plasmodium falciparum. Sci Rep 9(1):13542. https:\/\/doi.org\/10.1038\/s41598-019-49841-3","journal-title":"Sci Rep"},{"issue":"5","key":"5757_CR35","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1365-2958.2004.04257.x","volume":"53","author":"S Muller","year":"2004","unstructured":"Muller S (2004) Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol 53(5):1291\u20131305. https:\/\/doi.org\/10.1111\/j.1365-2958.2004.04257.x","journal-title":"Mol Microbiol"},{"issue":"6","key":"5757_CR36","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acs.bioconjchem.3c00147","volume":"34","author":"IR Palombi","year":"2023","unstructured":"Palombi IR et al (2023) Development of antiplasmodial peptide-drug conjugates using a human protein-derived cell-penetrating peptide with selectivity for infected cells. Bioconjug Chem 34(6):1105\u20131113. https:\/\/doi.org\/10.1021\/acs.bioconjchem.3c00147","journal-title":"Bioconjug Chem"},{"issue":"6421","key":"5757_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/362643a0","volume":"362","author":"SA Desai","year":"1993","unstructured":"Desai SA, Krogstad DJ, McCleskey EW (1993) A nutrient-permeable channel on the intraerythrocytic malaria parasite. Nature 362(6421):643\u2013646. https:\/\/doi.org\/10.1038\/362643a0","journal-title":"Nature"},{"issue":"6799","key":"5757_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/35023000","volume":"406","author":"SA Desai","year":"2000","unstructured":"Desai SA, Bezrukov SM, Zimmerberg J (2000) A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature 406(6799):1001\u20131005. https:\/\/doi.org\/10.1038\/35023000","journal-title":"Nature"},{"issue":"5","key":"5757_CR39","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/S0021-9258(17)41868-0","volume":"269","author":"K Kirk","year":"1994","unstructured":"Kirk K et al (1994) Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel. J Biol Chem 269(5):3339\u20133347. https:\/\/doi.org\/10.1016\/S0021-9258(17)41868-0","journal-title":"J Biol Chem"},{"issue":"2","key":"5757_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","volume":"13","author":"NJ Spillman","year":"2013","unstructured":"Spillman NJ et al (2013) Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe 13(2):227\u2013237. https:\/\/doi.org\/10.1016\/j.chom.2012.12.006","journal-title":"Cell Host Microbe"},{"issue":"9","key":"5757_CR41","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.bcp.2009.12.025","volume":"79","author":"DA van Schalkwyk","year":"2010","unstructured":"van Schalkwyk DA et al (2010) Inhibition of Plasmodium falciparum pH regulation by small molecule indole derivatives results in rapid parasite death. Biochem Pharmacol 79(9):1291\u20131299. https:\/\/doi.org\/10.1016\/j.bcp.2009.12.025","journal-title":"Biochem Pharmacol"},{"key":"5757_CR42","doi-asserted-by":"publisher","unstructured":"Tong JX, Chandramohanadas R, Tan KS (2018) High-content screening of the medicines for Malaria venture pathogen box for Plasmodium falciparum digestive vacuole-disrupting molecules reveals valuable starting points for drug discovery. Antimicrob Agents Chemother 62(3). https:\/\/doi.org\/10.1128\/AAC.02031-17","DOI":"10.1128\/AAC.02031-17"},{"issue":"15\u201316","key":"5757_CR43","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","volume":"17","author":"F Milletti","year":"2012","unstructured":"Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17(15\u201316):850\u2013860. https:\/\/doi.org\/10.1016\/j.drudis.2012.03.002","journal-title":"Drug Discov Today"},{"key":"5757_CR44","doi-asserted-by":"publisher","unstructured":"Gare CL et al (2024) Exploring the utility of cell-penetrating peptides as vehicles for the delivery of distinct antimalarial drug cargoes. ChemMedChem e202400637. https:\/\/doi.org\/10.1002\/cmdc.202400637","DOI":"10.1002\/cmdc.202400637"},{"key":"5757_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12936-016-1130-z","volume":"15","author":"PN Tran","year":"2016","unstructured":"Tran PN et al (2016) Changes in lipid composition during sexual development of the malaria parasite Plasmodium falciparum. Malar J 15:73. https:\/\/doi.org\/10.1186\/s12936-016-1130-z","journal-title":"Malar J"},{"key":"5757_CR46","doi-asserted-by":"publisher","first-page":"926541","DOI":"10.3389\/fcimb.2022.926541","volume":"12","author":"J Wunderlich","year":"2022","unstructured":"Wunderlich J (2022) Updated list of transport proteins in Plasmodium falciparum. Front Cell Infect Microbiol 12:926541. https:\/\/doi.org\/10.3389\/fcimb.2022.926541","journal-title":"Front Cell Infect Microbiol"},{"key":"5757_CR47","doi-asserted-by":"publisher","unstructured":"Dennis ASM et al (2018) Cell swelling induced by the antimalarial KAE609 (Cipargamin) and other PfATP4-associated antimalarials. Antimicrob Agents Chemother 62(6). https:\/\/doi.org\/10.1128\/AAC.00087-18","DOI":"10.1128\/AAC.00087-18"},{"issue":"5","key":"5757_CR48","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1128\/AAC.01342-07","volume":"52","author":"C Gelhaus","year":"2008","unstructured":"Gelhaus C et al (2008) The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic plasmodium falciparum. Antimicrob Agents Chemother 52(5):1713\u20131720. https:\/\/doi.org\/10.1128\/AAC.01342-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5757_CR49","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1128\/AAC.44.9.2442-2451.2000","volume":"44","author":"M Krugliak","year":"2000","unstructured":"Krugliak M et al (2000) Antimalarial activities of dermaseptin S4 derivatives. Antimicrob Agents Chemother 44(9):2442\u20132451. https:\/\/doi.org\/10.1128\/AAC.44.9.2442-2451.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5757_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12936-021-03849-1","volume":"20","author":"CLL Chua","year":"2021","unstructured":"Chua CLL et al (2021) Factors influencing phagocytosis of malaria parasites: the story so far. Malar J 20(1):319. https:\/\/doi.org\/10.1186\/s12936-021-03849-1","journal-title":"Malar J"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05757-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05757-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:04:39Z","timestamp":1756389879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05757-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5757"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05757-y","relation":{},"ISSN":["1420-9071"],"issn-type":[{"type":"electronic","value":"1420-9071"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to update acknowledgment section in the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experimental procedures involving human blood were approved by the Australian National University Human Research Ethics Committee, approval number 2018\/398.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}